LFWD
$7.56
Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally.
Recent News
Lifeward Ltd (LFWD) Q4 2025: Everything You Need To Know Ahead Of Earnings
This article first appeared on GuruFocus. Lifeward Ltd (NASDAQ:LFWD) is set to release its Q4 2025 earnings on Mar 18, 2026. The consensus estimate for Q4 2025 revenue is $7.86 million, and the earnings are expected to come in at -$1.08 per share.
Lifeward Ltd (LFWD) Q3 2025 Earnings Call Highlights: Navigating Growth and Challenges
Lifeward Ltd (LFWD) reports modest revenue growth, strategic advancements, and financial hurdles in its Q3 2025 earnings call.
Lifeward (LFWD) Q3 2025 Earnings Call Transcript
William Mark Grant: Thank you, Almog. Since joining Lifeward Ltd. in June, I have completed a sober and comprehensive assessment of the business, starting with our strategic direction down to our commercial model and operations.
Market Sentiment Around Loss-Making Lifeward Ltd. (NASDAQ:LFWD)
We feel now is a pretty good time to analyse Lifeward Ltd.'s ( NASDAQ:LFWD ) business as it appears the company may be...
Lifeward: Q3 Earnings Snapshot
MARLBOROUGH, Mass. AP) — Lifeward Ltd. (LFWD) on Friday reported a loss of $3.2 million in its third quarter. The Marlborough, Massachusetts-based company said it had a loss of 20 cents per share.